Delivery Order SPE2DB20D2014-SPE2DB24FC11W

Award Date 6/3/24
Potential Completion Date 6/4/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,248.61 firm-fixed-price delivery order is for the supply of Eliquis 5 mg tablets to the DLA. The contract has an ultimate completion date of June 7, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Eliquis 5 mg tablets. The $16,941.06 delivery order contract has an ultimate completion date of May 2, 2024 and was awarded on May 1, 2024 by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Eliquis 5 mg tablets to the U.S. government. The $4,594.80 Firm Fixed Price Delivery Order was awarded on June 24, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency of the Department of Defense, with an ultimate completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $37,726.57 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of Eliquis 5 mg tablets, a prescription medication, with a period of performance through June 6, 2024. This order is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Eliquis 5 mg tablet 60s to the Defense Logistics Agency (DLA). The $4,451.74 firm-fixed-price delivery order contract has a completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Medical Supply Chain division of the U.S. Department of Defense to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,583.40 firm-fixed-price delivery order is for the supply of 4,564,618,633 units of Eliquis 2.5 mg tablets. The contract has a completion date of May 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The $1,811.20 firm fixed-price delivery order has a completion date of July 1, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Eliquis 5 mg tablets to the U.S. government. The contract has a total ceiling value of $14,855.02 and an ultimate completion date of May 24, 2024. The contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $36,495.89 Firm Fixed Price delivery order is for the supply of 4,564,814,441 tablets of the prescription medication Eliquis 5 mg. The contract has a completion date of June 6, 2024. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $25,140.02 for the supply of Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD), and has a completion date of July 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC11W
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide Eliquis 5 mg tablets to the Department of Defense (DoD). The $11,667.23 firm-fixed price Delivery Order was awarded on June 3, 2024, with a completion date of June 4, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a wide range of pharmaceutical products and medical supplies to DLA facilities worldwide. This contract does not have a set-aside designation. Amerisourcebergen also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 9/2/24, 3:52 PM